赛伦生物
(688163)
| 流通市值：36.20亿 | | | 总市值：36.20亿 |
| 流通股本：1.08亿 | | | 总股本：1.08亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 173,014,008.95 | 104,210,450.98 | 27,093,556.95 | 196,205,881.77 |
| 营业收入 | 173,014,008.95 | 104,210,450.98 | 27,093,556.95 | 196,205,881.77 |
| 二、营业总成本 | 104,235,264.37 | 65,411,608.53 | 28,203,094.58 | 140,513,815.84 |
| 营业成本 | 37,268,907.25 | 22,633,964.76 | 7,408,817.55 | 42,928,672.49 |
| 税金及附加 | 2,522,330.12 | 1,674,556.8 | 351,904.41 | 1,953,928.87 |
| 销售费用 | 30,648,463.65 | 19,528,468.32 | 10,023,113.23 | 55,042,236.07 |
| 管理费用 | 18,077,198.07 | 10,827,018.16 | 5,587,087.98 | 22,421,196.68 |
| 研发费用 | 15,675,448.16 | 10,678,265.77 | 4,800,348.65 | 19,508,321.24 |
| 财务费用 | 42,917.12 | 69,334.72 | 31,822.76 | -1,340,539.51 |
| 其中:利息费用 | 17,603.64 | 90,417.7 | 39,148.35 | 179,655.32 |
| 其中:利息收入 | 602,017.99 | 397,123.89 | 188,742.12 | 1,614,867.62 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,949,712.1 | 2,030,487.45 | 949,071.23 | 1,409,182.18 |
| 加:投资收益 | 5,497,115.65 | 3,784,309.65 | 2,180,740.55 | 9,175,924.27 |
| 资产处置收益 | 14,154.22 | 14,154.22 | -325,061.45 | 80,366.33 |
| 资产减值损失(新) | -2,678,383.6 | -2,158,254.63 | -676,262.46 | -2,075,092.97 |
| 信用减值损失(新) | -2,167,198.84 | -2,128,363.75 | -669,063.77 | -280,023.37 |
| 其他收益 | 250,815.4 | 212,773.06 | 123,133.96 | 504,649.73 |
| 四、营业利润 | 72,644,959.51 | 40,553,948.45 | 473,020.43 | 64,507,072.1 |
| 加:营业外收入 | 3,600 | 3,600 | - | 90,409.71 |
| 减:营业外支出 | 812,173.06 | 599,573.06 | 52,576.68 | 391,270.16 |
| 五、利润总额 | 71,836,386.45 | 39,957,975.39 | 420,443.75 | 64,206,211.65 |
| 减:所得税费用 | 8,764,320.4 | 4,306,671.03 | -146,732.4 | 12,418,815.13 |
| 六、净利润 | 63,072,066.05 | 35,651,304.36 | 567,176.15 | 51,787,396.52 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 63,072,066.05 | 35,651,304.36 | 567,176.15 | 51,787,396.52 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 63,072,066.05 | 35,651,304.36 | 567,176.15 | 51,787,396.52 |
| 扣除非经常损益后的净利润 | 56,421,339.89 | 31,083,190.44 | -2,090,410.7 | 42,632,839.88 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.58 | 0.33 | 0.01 | 0.48 |
| (二)稀释每股收益 | 0.58 | 0.33 | 0.01 | 0.48 |
| 九、综合收益总额 | 63,072,066.05 | 35,651,304.36 | 567,176.15 | 51,787,396.52 |
| 归属于母公司股东的综合收益总额 | 63,072,066.05 | 35,651,304.36 | 567,176.15 | 51,787,396.52 |
| 公告日期 | 2026-10-28 | 2026-08-22 | 2026-04-25 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |